Stem Cell Transplant News

CancerConnect stem cell transplant news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of stem cell transplant research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of stem cell transplant treatment and survivorship.

Share

Stem Cell Transplant News


Duration of Blood Storage Does Not Affect Outcomes for Patients Requiring Blood Transfusions (December 1, 2016)

The length of time that blood is stored prior to a blood transfusion, within normal ranges, does not appear to affect mortality among patients requiring transfusions. These results were recently published... Continue Reading

Defitelio® Approved for Life-Threatening Complication of Stem Cell Transplant (March 30, 2016)

The United States Food and Drug Administration (FDA) has approved Defitelio® (defibrotide sodium) for the treatment of hepatic veno-occlusive disease (VOD) following a stem cell transplant. Defitelio... Continue Reading

Myeloablative Treatment Regimens Superior to Reduced Intensity Treatment for AML and MDS Patients Undergoing Stem Cell Transplant (December 30, 2015)

Hematopoietic Stem Cell Transplant (SCT) is a standard and potentially curative treatment for individuals with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Historically only high dose... Continue Reading

Data Back Stem Cell Transplant as Cure for Sickle Cell (December 28, 2015)

A recent report suggests that over 90% of patients with sickle cell disease treated with an HLA-matched sibling stem-cell transplant (SCT) survive, free of disease, 3 years after treatment and are probably... Continue Reading

Prospective Study Shows Age Doesn’t Affect Survival Outcomes in Patients with Myelodysplastic Syndrome (MDS) Who Receive a Hematopoietic Cell Transplant (HCT) (December 14, 2015)

Results from a prospective study of 1,280 patients with myelodysplastic syndrome (MDS) showed that survival at 100 days and at two years following hematopoietic cell transplant (HCT) for patients aged... Continue Reading

Promising Survival for AML Patients Treated with Stem Cells from Related Half Matched Donor (July 30, 2015)

Patients with acute myeloid leukemia (AML) may have a promising new treatment option. Research shows that stem cell transplant from a “half matched” related donor plus chemotherapy results in similar... Continue Reading

Phase II Clinical Trial Shows Stem Cell Transplantation Effective For Severe Multiple Sclerosis Treatment (February 26, 2015)

A study published in the journal Neurology reveals that stem cell transplantation could be a more effective therapy in severe cases of multiple sclerosis (MS) than the drug mitoxantrone. The study is entitled... Continue Reading

Reduced-Intensity Stem Cell Transplant Minimizes Effects on Mental Functioning (December 20, 2013)

In contrast to full-intensity stem cell transplants, reduced-intensity stem-cell transplants appear to have little effect on cognitive function. These results were presented at the 2013 Annual Meeting... Continue Reading

Treatment with Early Stem Cell Transplant Improves Outcomes in Aggressive NHL (November 12, 2013)

Early autologous stem cell transplantation resulted in improved progression-free survival in patients with high-intermediate risk or high-risk disease who experienced a response to induction therapy, according... Continue Reading

Antiretroviral Drug May Prevent Graft-Versus-Host Disease (August 6, 2012)

The drug Selzentry® (maraviroc), which is typically used to treat HIV infection, may help prevent graft-versus-host disease (GVHD), a potentially lethal complication of stem cell transplants, according... Continue Reading

More Stem Cell Transplant News

Latest Stem Cell Transplant News By Stage


Allogeneic

Myeloablative Treatment Regimens Superior to Reduced Intensity Treatment for AML and MDS Patients Undergoing Stem Cell Transplant (December 30, 2015)

Hematopoietic Stem Cell Transplant (SCT) is a standard and potentially curative treatment for individuals with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Historically only high dose myeloablative treatment regimens were utilized since... Continue Reading

Data Back Stem Cell Transplant as Cure for Sickle Cell (December 28, 2015)

A recent report suggests that over 90% of patients with sickle cell disease treated with an HLA-matched sibling stem-cell transplant (SCT) survive, free of disease, 3 years after treatment and are probably cured. The report summarized the results of 1,000... Continue Reading

Promising Survival for AML Patients Treated with Stem Cells from Related Half Matched Donor (July 30, 2015)

Patients with acute myeloid leukemia (AML) may have a promising new treatment option. Research shows that stem cell transplant from a “half matched” related donor plus chemotherapy results in similar survival as a transplant from an unrelated matched... Continue Reading

Antiretroviral Drug May Prevent Graft-Versus-Host Disease (August 6, 2012)

The drug Selzentry® (maraviroc), which is typically used to treat HIV infection, may help prevent graft-versus-host disease (GVHD), a potentially lethal complication of stem cell transplants, according to the results of a study published in the New England... Continue Reading

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

A study of “chemo brain”—the foggy thinking and forgetfulness that patients may experience after chemotherapy—suggests that the condition improves substantially over time for a majority of patients. For some patients, however, symptoms may persist... Continue Reading

More Allogeneic

Autologous

Treatment with Early Stem Cell Transplant Improves Outcomes in Aggressive NHL (November 12, 2013)

Early autologous stem cell transplantation resulted in improved progression-free survival in patients with high-intermediate risk or high-risk disease who experienced a response to induction therapy, according to the results of a study published in the... Continue Reading

Complementary Therapy for Children Undergoing Stem Cell Transplant (July 19, 2010)

Complementary therapies such as massage and humor therapy may not help children cope with the potential emotional distress associated with stem cell transplantation, according to findings recently reported in Cancer. Stem cell transplantation involves... Continue Reading

Kepivance Reduces Toxicity of High-dose Therapy for Multiple Myeloma (March 24, 2010)

Among patients undergoing high-dose therapy and autologous stem cell transplantation for multiple myeloma, a three-day short course of Kepivance® (palifermin) reduces the toxicity of treatment. These results were published in the Annals of Oncology. Multiple... Continue Reading

Stem Cell Transplant Procedures Vary Throughout the World (May 9, 2008)

Stem Cell Transplant Procedures Vary Throughout the World Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood or bone marrow such as leukemias and lymphomas).... Continue Reading

MCP Chemotherapy Regimen May Reduce Amount of Stem Cells Collected in Follicular Lymphoma (February 1, 2007)

MCP Chemotherapy Regimen May Reduce Amount of Stem Cells Collected in Follicular Lymphoma According to results recently published in Annals of Oncology, the chemotherapy regimen consisting of melphalan, chlorambucil, and prednisone (MCP) appears to interfere... Continue Reading

More Autologous

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS